ADIRONDACK TRUST CO – Regeneron Pharmaceuticals, Inc. Transaction History
ADIRONDACK TRUST CO portfolio value:
$329,000
portfolio value
ADIRONDACK TRUST CO quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.00% | 27 shares | 63K | $688.87 | 477 |
| Q2 2022 | share | Increase | +14.50% | 57 shares | -8K | $591.13 | 450 |
| Q1 2022 | share | Increase | +47.74% | 127 shares | 106K | $698.42 | 393 |
| Q4 2021 | share | Increase | +1.53% | 4 shares | 0 | $642.51 | 266 |
| Q3 2021 | share | Increase | +4.38% | 11 shares | 28K | $605.18 | 262 |
| Q2 2021 | share | 0.00% | 0 shares | 21K | $558.54 | 251 | |
| Q1 2021 | share | Increase | +126.13% | 140 shares | 63K | $473.14 | 251 |
| Q4 2020 | share | Increase | +2.78% | 3 shares | -4K | $483.11 | 111 |
| Q3 2020 | share | 0.00% | 0 shares | -8K | $559.78 | 108 | |
| Q2 2020 | share | 0.00% | 0 shares | 15K | $623.65 | 108 | |
| Q1 2020 | share | Increase | +4.85% | 5 shares | 18K | $488.29 | 108 |
| Q4 2019 | share | Decrease | -21.37% | -28 shares | -1K | $375.48 | 103 |
| Q3 2019 | share | 0.00% | 0 shares | -5K | $277.4 | 131 | |
| Q2 2019 | share | 0.00% | 0 shares | -4K | $313 | 131 | |
| Q1 2019 | share | 0.00% | 0 shares | -4K | $410.62 | 131 | |
| Q4 2018 | share | Decrease | -6.43% | -9 shares | -8K | $373.5 | 131 |
| Q3 2018 | share | Increase | +3.70% | 5 shares | 10K | $404.04 | 140 |
| Q2 2018 | share | 0.00% | 0 shares | 6K | $344.99 | 135 | |
| Q1 2018 | share | Increase | +35.00% | 35 shares | 3K | $344.36 | 135 |
| Q4 2017 | share | 0.00% | 0 shares | -7K | $375.96 | 100 | |
| Q3 2017 | share | 0.00% | 0 shares | -4K | $447.12 | 100 | |
| Q2 2017 | share | Decrease | -13.04% | -15 shares | 4K | $491.14 | 100 |
| Q1 2017 | share | Decrease | -32.35% | -55 shares | -17K | $387.51 | 115 |
| Q4 2016 | share | 0.00% | 0 shares | -6K | $367.09 | 170 | |
| Q3 2016 | share | Increase | +47.83% | 55 shares | 28K | $402.02 | 170 |
| Q2 2016 | share | 0.00% | 0 shares | -1K | $349.23 | 115 | |
| Q1 2016 | share | 0.00% | 0 shares | -7K | $360.44 | 115 |